New York, New York, United States The company was established in North America in United States. The leading representative office of defined VC is situated in the New York.
The overall number of key employees were 1.
The high activity for fund was in 2016. The common things for fund are deals in the range of 5 - 10 millions dollars. The increased amount of exits for fund were in 2008. The fund is constantly included in less than 2 deals per year.
The typical case for the fund is to invest in rounds with 6-7 participants. Despite the Auriga Capital Management, startups are often financed by Soros Fund Management, Pontifax, Perceptive Advisors. The meaningful sponsors for the fund in investment in the same round are Pontifax, Perceptive Advisors, Commercial Street Capital. In the next rounds fund is usually obtained by Pontifax, Perceptive Advisors, Commercial Street Capital.
Among the most successful fund investment fields, there are Biotechnology, Biopharma. Among the various public portfolio startups of the fund, we may underline Arno Therapeutics For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Moreover, a startup needs to be at the age of 16-20 years to get the investment from the fund.
Related Funds
| Fund Name | Location |
| CDIB Capital | China, Hong Kong, Hong Kong Island |
| Centre Palisades Ventures | California, Los Angeles, United States |
| Daiwa Food & Agriculture | Japan, Tokyo |
| Draft Ventures | California, San Francisco, United States |
| Hulic | Japan, Tokyo |
| KIN Capital | Chengdu, China, Sichuan |
| Lightheart Management Partners | British Columbia, Canada, Vancouver |
| SnapChat | California, United States, Venice |
| St. Petersburg Downtown Partnership | - |
| Tichenor Ventures | Dallas, Texas, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 